الوصف

Curcumin supplementation alongside 5-aminosalicylic acid therapy for ulcerative colitis demonstrates potential additive benefits. Combination therapy outcomes exceed those of standard treatment alone in several measures.

Figure 27

Chart

Source Paper

The Use of Curcumin as a Complementary Therapy in Ulcerative Colitis: A Systematic Review of Randomized Controlled Clinical Trials.

Nutrients (2020)

PMID: 32751776

DOI: 10.3390/nu12082296

Cite This Figure

![Figure 27: Curcumin supplementation alongside 5-aminosalicylic acid therapy for ulcerative colitis demonstrates potential additive benefits. Combination therapy outcomes exceed those of standard treatment alone in several measures.]()

> Source: Mariana Roque Coelho et al. "The Use of Curcumin as a Complementary Therapy in Ulcerative Colitis: A Systemat." *Nutrients*, 2020. PMID: [32751776](https://pubmed.ncbi.nlm.nih.gov/32751776/)

<figure>
  <img src="" alt="Curcumin supplementation alongside 5-aminosalicylic acid therapy for ulcerative colitis demonstrates potential additive benefits. Combination therapy outcomes exceed those of standard treatment alone in several measures." />
  <figcaption>Figure 27. Curcumin supplementation alongside 5-aminosalicylic acid therapy for ulcerative colitis demonstrates potential additive benefits. Combination therapy outcomes exceed those of standard treatment alone in several measures.<br>  Source: Mariana Roque Coelho et al. "The Use of Curcumin as a Complementary Therapy in Ulcerative Colitis: A Systemat." <em>Nutrients</em>, 2020. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/32751776/">32751776</a></figcaption>
</figure>

أدلة ذات صلة

Curcumin لـ Ulcerative Colitis (UC)

التقييم B · 5 دراسات

Curcumin لـ Crohn's Disease

التقييم C · 3 دراسات